264.69
0.11%
0.30
Pre-market:
266.43
1.74
+0.66%
Overview
News
Price History
Option Chain
Financials
Why EFX Down?
Discussions
Forecast
Stock Split
Dividend History
Equifax Inc stock is traded at $264.69, with a volume of 779.74K.
It is up +0.11% in the last 24 hours and down -6.67% over the past month.
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
See More
Previous Close:
$264.39
Open:
$264.99
24h Volume:
779.74K
Relative Volume:
0.86
Market Cap:
$32.72B
Revenue:
$5.59B
Net Income/Loss:
$562.50M
P/E Ratio:
62.72
EPS:
4.22
Net Cash Flow:
$783.50M
1W Performance:
-1.97%
1M Performance:
-6.67%
6M Performance:
+16.58%
1Y Performance:
+45.58%
Equifax Inc Stock (EFX) Company Profile
Name
Equifax Inc
Sector
Industry
Phone
(404) 885-8000
Address
1550 PEACHTREE ST NW, ATLANTA, GA
Equifax Inc Stock (EFX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-01-24 | Initiated | UBS | Buy |
Sep-19-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Aug-13-24 | Initiated | Wells Fargo | Overweight |
Jul-09-24 | Initiated | Wolfe Research | Outperform |
Feb-13-24 | Upgrade | Evercore ISI | In-line → Outperform |
Jan-11-24 | Downgrade | Redburn Atlantic | Buy → Neutral |
Jan-08-24 | Upgrade | BofA Securities | Underperform → Buy |
Jan-04-24 | Reiterated | Needham | Buy |
Dec-19-23 | Initiated | Oppenheimer | Outperform |
Dec-18-23 | Upgrade | Jefferies | Hold → Buy |
Dec-15-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Dec-08-23 | Upgrade | Deutsche Bank | Hold → Buy |
Nov-20-23 | Initiated | Citigroup | Buy |
Jul-24-23 | Downgrade | BofA Securities | Neutral → Underperform |
Jan-06-23 | Initiated | Exane BNP Paribas | Underperform |
Nov-15-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
Oct-21-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Oct-19-22 | Downgrade | Jefferies | Buy → Hold |
Aug-16-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Aug-15-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Jul-13-22 | Initiated | Wells Fargo | Equal Weight |
Apr-21-22 | Downgrade | Evercore ISI | Outperform → In-line |
Mar-30-22 | Initiated | Deutsche Bank | Hold |
Mar-11-22 | Resumed | BofA Securities | Neutral |
Jan-31-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Jan-27-22 | Upgrade | Truist | Hold → Buy |
Jan-24-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-05-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-22-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Oct-22-21 | Upgrade | Argus | Hold → Buy |
Oct-15-21 | Resumed | Evercore ISI | Outperform |
Jul-23-21 | Reiterated | Goldman | Neutral |
Jul-08-21 | Initiated | RBC Capital Mkts | Sector Perform |
Dec-15-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
Dec-11-20 | Upgrade | Stifel | Hold → Buy |
Dec-08-20 | Upgrade | Barclays | Equal Weight → Overweight |
Oct-07-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Oct-06-20 | Initiated | Needham | Buy |
Jul-10-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Jun-09-20 | Downgrade | SunTrust | Buy → Hold |
May-15-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-06-20 | Downgrade | Argus | Buy → Hold |
Mar-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-02-20 | Upgrade | Exane BNP Paribas | Underperform → Outperform |
Jan-17-20 | Upgrade | Argus | Hold → Buy |
Nov-22-19 | Initiated | Jefferies | Buy |
Mar-15-19 | Initiated | Exane BNP Paribas | Underperform |
Feb-05-19 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-07-18 | Resumed | Credit Suisse | Outperform |
Oct-26-18 | Reiterated | Barclays | Equal Weight |
Oct-23-18 | Resumed | BofA/Merrill | Underperform |
Apr-10-18 | Initiated | BofA/Merrill | Underperform |
Dec-14-17 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Equifax Inc Stock (EFX) Latest News
New York State Common Retirement Fund Sells 12,999 Shares of Equifax Inc. (NYSE:EFX) - MarketBeat
Equifax Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Equifax Inc. (NYSE:EFX) Shares Sold by Van ECK Associates Corp - MarketBeat
abrdn plc Has $14.44 Million Position in Equifax Inc. (NYSE:EFX) - MarketBeat
Equifax Inc. (NYSE:EFX) Shares Sold by New York State Teachers Retirement System - MarketBeat
Equifax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The big 3 credit bureaus and the info they gather about you - Britannica
Mirae Asset Global Investments Co. Ltd. Purchases 2,379 Shares of Equifax Inc. (NYSE:EFX) - MarketBeat
Equifax Doesn't Report Ch. 7 Discharges, Suit Says - Law360
Equifax Inc. stock outperforms competitors on strong trading day - MarketWatch
Equifax Inc. (NYSE:EFX) Delivered A Weaker ROE Than Its Industry - Yahoo Finance
Equifax Inc. (NYSE:EFX) Receives $310.47 Consensus Target Price from Analysts - MarketBeat
Equifax Inc. (NYSE:EFX) EVP John J. Kelley III Sells 1,000 Shares - MarketBeat
Equifax's chief legal officer sells $272,920 in stock - Investing.com India
BDC, Equifax launch Small Business Health Index to take pulse of Canada's SMEs - Financial Post
Boston Financial Mangement LLC Boosts Position in Equifax Inc. (NYSE:EFX) - MarketBeat
How to Freeze and Unfreeze Your Credit with All 3 Bureaus - NerdWallet
Equifax Inc. stock rises Monday, still underperforms market - MarketWatch
BDC And Equifax Launch Innovative Canadian Small Business Health Index - Barchart
Equifax (NYSE:EFX) Stock Rating Reaffirmed by Needham & Company LLC - MarketBeat
Equifax Inc. (NYSE:EFX) Shares Purchased by Forsta AP Fonden - MarketBeat
What to Expect From Equifax's Q3 2024 Earnings Report - MSN
Equifax Inc. (NYSE:EFX) Shares Sold by Mediolanum International Funds Ltd - MarketBeat
What is 3-bureau credit monitoring and how to get it - CNBC
Equifax Inc. stock remains steady Thursday, underperforms market - MarketWatch
New to Canada? A new way to transfer your credit score - MoneySense
OneID and Equifax UK to simplify customer onboarding with new digital ID tool - Biometric Update
Equifax launches foreign credit score sourcing program for newcomers - The Albertan
Newcomers can transfer foreign credit history in new Equifax program - Global News Toronto
Equifax Canada Champions Financial Inclusion for Newcomers to Canada with the Launch of Global Consumer Credit File - Owen Sound Sun Times
Equifax's SWOT analysis: stock outlook amid forecasting challenges - Investing.com
Equifax launches new service to aid newcomers to Canada - The Globe and Mail
Equifax Inc. stock outperforms competitors despite losses on the day - MarketWatch
Lecap Asset Management Ltd. Buys Shares of 15,659 Equifax Inc. (NYSE:EFX) - MarketBeat
Signaturefd LLC Sells 3,274 Shares of Equifax Inc. (NYSE:EFX) - MarketBeat
Equifax (EFX) Price Target Increased by 5.58% to 277.10 - MSN
Equifax: Stay Buy Rated As Medium-Term Growth Outlook Remains Positive (NYSE:EFX) - Seeking Alpha
Frontline Education Partners with Equifax® to Bring The Work Number® to ERP Clients in Texas and California - Yahoo Finance
Equifax (NYSE:EFX) Shareholders Will Want The ROCE Trajectory To Continue - Yahoo Finance
Decoding Equifax Inc (EFX): A Strategic SWOT Insight - Yahoo Finance
Equifax (EFX) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Raymond James & Associates Increases Stock Position in Equifax Inc. (NYSE:EFX) - MarketBeat
Equities Analysts Offer Predictions for Equifax Q2 Earnings - MarketBeat
Equifax Gears up to Report Q3 Earnings: What's in the Offing? - MSN
Buy Equifax Ahead of Potential Earnings Beat and Solid Upside - MSN
Generate Investment Management Ltd Buys 9,437 Shares of Equifax Inc. (NYSE:EFX) - MarketBeat
Equifax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Equifax (NYSE:EFX) Price Target Increased to $304.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Equifax Inc Stock (EFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):